Semaglutide’s cardiovascular benefits extend beyond weight loss: systemic metabolic pathways and structural health inequities revealed
Original framing: “[Correspondence] Semaglutide, weight loss, and cardiovascular outcomes in the SELECT trial” — The Lancet
The SELECT trial’s prespecified analyses reveal that semaglutide’s cardiovascular benefits are not solely mediated by weight loss, implicating direct metabolic effects such as improved insulin sensitivity, reduced inflammation, and enhanced endothelial function. GLP-1 agonists like semaglutide act on the gut-brain axis, modulating appetite and satiety while also reducing oxidative stress and atherosclerosis progression. However, the trial’s reliance on a predominantly White, high-income cohort limits generalizability, as metabolic responses to GLP-1 agonists vary across ethnicities due to genetic and microbiome differences. Future research must incorporate diverse populations to validate these findings.
The SELECT trial’s data reveals semaglutide’s cardiovascular benefits as a symptom of deeper systemic failures in how metabolic health is understood and addressed.
While the pharmaceutical industry and Western biomedicine frame obesity as a personal failing solvable by a pill, Indigenous traditions and Global South systems offer holistic models that integrate diet, movement, and spiritual balance. The trial’s narrow focus on waist circumference and MACE reduction obscures the structural drivers of metabolic dysfunction—corporate agribusiness, healthcare inequities, and colonial legacies—that shape health outcomes far more than individual behavior. A systemic solution requires dismantling these structures while leveraging semaglutide’s metabolic insights within culturally grounded frameworks. The trickster’s wisdom reminds us that the most absurd edge of this crisis is the belief that a single drug can outpace the need for justice in food systems, healthcare access, and environmental health. Future metabolic medicine must be pluralistic, participatory, and rooted in the wisdom of those who have long navigated these imbalances without pharmaceutical intervention.